Proteinea

#Industrial Biotech #Biomanufacturing / Pharmaceutical Services

• Recombinant protein production
• Next-gen bio manufacturing platform
• Synthetic biology
• Metabolic engineering
• Bioproduction
• Bio-sourced molecules
• Bioeconomics / Sustainable development

Background

Proteinea is an insect-based biotechnology startup. Proteinea defines the economics of building with biology by offering a one-step process to produce high-quality recombinant proteins of interest in an affordable, environmentally sustainable, and predictable manner.

Description of the Products / Services / Technology

Proteinea is integrating biology with engineering and molecular sciences to build the next-gen bio-manufacturing platform. Proteinea has developed a patent-pending technology, called InsectaPro, for using insects as mini-bioreactors to produce recombinant proteins on a scale at a significantly lower cost. It’s robust, scalable, and significantly more advantageous than conventional bioreactors.

Proteinea has a production as a service model (PaaS), in which the company secures partnerships with companies to sustainably produce (biobased and biodegradable) proteins/enzymes of interest in order to significantly reduce their environmental impact and produce at a large-scale and competitive cost coupled with high quality.

Customer references / Collaborations / Highlights

Proteinea joined IndieBio, the largest biotech accelerator, in during the winter/spring 2021 cohort.

Collaborations Sought

One of the areas Proteinea is aiming to collaborate is in the vaccine production field.

• Further information

  4 Patents

  15 Staff members

  Strengths:
  Proteinea is offering a one-step process to produce high-quality recombinant proteins of interest in an affordable, environmentally sustainable, and predictable manner.

  Innovation Assets:
  Using insects as mini-bioreactors to produce recombinant proteins on a scale at a significantly lower cost.